IN.PACT™ ADMIRAL™ DRUG COATED BALLOON
Maintain long-term vessel patency with the IN.PACT™ Admiral™ drug-coated balloon, the market-leading DCB for treatment of femoropopliteal disease with 75% of patients reintervention-free at 5 years.1
IN.PACT Admiral DCB Overview Video - (03:11)
Watch video to learn more about the IN.PACT Admiral DCB's product details, clinical evidence, and patient benefit.
More information (see more) Less information (see less)
Laird J, Schneider P, Jaff MR, et al. Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions. 5-year results from the IN.PACT SFA Trial. Circ Cardiovasc Interv. June 2019;12(6):e007702.